We are live on ! Find out more
SRTSW

Sensus Healthcare, Inc. Warrant expiring on 06/08/2020

Delisted

SRTSW was delisted on the 4th of June, 2020.

3 hedge funds and large institutions have $39K invested in Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

20% less capital invested

Capital invested by funds: $49K → $39K (-$10K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$412

Top Sellers

No sellers this quarter

SRTSW Hedge Fund Activity: Q3 2019 in Review

3 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 (SRTSW) for Q3 2019, worth a combined $39K — down 20% from $49K a quarter earlier.

Fund positioning in SRTSW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $412.

  • 3 institutional investors held Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 (SRTSW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $39K of Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 stock for Q3 2019, down 20% quarter-over-quarter.
  • 0 funds opened new Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 positions in Q3 2019 and 0 closed out.
  • The largest Sensus Healthcare, Inc. Warrant expiring on 06/08/2020 buyer in Q3 2019 was Susquehanna International Group, an estimated $412 added.

Based on aggregated 13F filings for Q3 2019.